Imunon
Stock Forecast, Prediction & Price Target
Imunon Financial Estimates
Imunon Revenue Estimates
Imunon EBITDA Estimates
Imunon Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $500K N/A | $500K 0% | $0 -100% | Avg: $10.42M Low: $10.42M High: $10.42M avg. 0% | Avg: $3.93M Low: $3.93M High: $3.93M avg. -62.28% | Avg: $17.15M Low: $17.15M High: $17.15M avg. 336.01% | Avg: $43.95M Low: $43.95M High: $43.95M avg. 156.26% |
Net Income
% change YoY
| $-20.76M N/A | $-35.89M -72.84% | $-19.51M 45.63% | Avg: $-25.55M Low: $-23.06M High: $-6.60M avg. -30.95% | Avg: $-38.7M Low: $-25.77M High: $-5.96M avg. -51.43% | Avg: $-4.97M Low: $-4.97M High: $-4.97M avg. 87.14% | Avg: $-3.25M Low: $-3.25M High: $-3.25M avg. 34.54% |
EBITDA
% change YoY
| $-19.38M N/A | $-19.52M -0.72% | $-19.87M -1.80% | Avg: $-6.25M Low: $-6.25M High: $-6.25M avg. 68.52% | Avg: $-2.35M Low: $-2.35M High: $-2.35M avg. 62.28% | Avg: $-10.29M Low: $-10.29M High: $-10.29M avg. -336.01% | Avg: $-26.37M Low: $-26.37M High: $-26.37M avg. -156.26% |
EPS
% change YoY
| -$57.41 N/A | -$5.03 91.23% | -$2.16 57.05% | Avg: -$1.64 Low: -$2.55 High: -$0.73 avg. 24.07% | Avg: -$1.76 Low: -$2.85 High: -$0.66 avg. -7.01% | Avg: -$0.55 Low: -$0.55 High: -$0.55 avg. 68.66% | Avg: -$0.36 Low: -$0.36 High: -$0.36 avg. 34.54% |
Operating Expenses
% change YoY
| $21.50M N/A | $25.42M 18.20% | $21.03M -17.27% | Avg: $169.85M Low: $169.85M High: $169.85M avg. 707.65% | Avg: $64.06M Low: $64.06M High: $64.06M avg. -62.28% | Avg: $279.32M Low: $279.32M High: $279.32M avg. 336.01% | Avg: $715.81M Low: $715.81M High: $715.81M avg. 156.26% |
FAQ
What is Imunon stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 9.82% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -23.06M, average is -25.55M and high is -6.60M.
What is Imunon stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 107.50% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $10.42M, average is $10.42M and high is $10.42M.
What is Imunon stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 30.06% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$2.55, average is -$1.64 and high is $-0.73.